Concepedia

Christoph L. Buenemann

CL

6

Publications

188

Citations

6

H-Index

1998

Active since

Affiliations

University of Tübingen(Current)

Novartis Institutes for BioMedical Research

Novartis (Austria)

Novartis (Switzerland)

Christoph L. Buenemann is an author at University of Tübingen specializing in medicine, signal transduction, and cell signaling.

Top concepts

Publications per year

1998–2015

6

Publications

6

Scaffold Hopping in De Novo Design. Ligand Generation in the Absence of Receptor Information

David G. Lloyd, Christoph L. Buenemann, Nikolay P. Todorov et al. · Journal of Medicinal Chemistry · 2003 · 62 citations

, , +20

Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cells

Christoph L. Buenemann · Carcinogenesis · 2001 · 40 citations · Full text

Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity

Albrecht Buchmann, Claudia Willy, Christoph L. Buenemann et al. · Cell Death and Differentiation · 1999 · 33 citations

, , +11

p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between Ras -mutated and Ras -wild-type lesions

Arno Kalkuhl, Jacob Troppmair, Albrecht Buchmann et al. · Hepatology · 1998 · 20 citations · Full text

FOCUS — Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists

Nikolaus Stiefl, Peter Gedeck, Donovan N. Chin et al. · Journal of Chemical Information and Modeling · 2015 · 20 citations

, , +22

Rows per page

1–5 of 6